A Mini-Review of Recent W.O. Patents (2004-2005) of Novel Anti-fungal Compounds in the Field of Anti-infective Drug Targets

Authors: Zhang, Weimin1; Becker, Donald1; Cheng, Qi1

Source: Recent Patents on Anti-Infective Drug Discovery, Volume 1, Number 2, June 2006 , pp. 225-230(6)

Publisher: Bentham Science Publishers

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Anti-infective agents are used to treat disorders caused by bacteria, viruses, protozoa, worms, and fungi (including yeast). They are substances used on humans, animals and plants that destroy harmful microorganisms or inhibit their activity. In this mini-review, we are focusing on novel development of anti-fungal agents that have been published during the past two years. Fungi are eukaryotic microorganisms comprising over 100,000 species. Nearly 40% of all deaths from hospital-acquired infections were caused by fungi over the past 20 years. An effective anti-fungal agent is toxic to the pathogenic fungi, but not to the host. Treatment of fungi diseases, however, is often limited because antifungal agents are often toxic to the mammalian or plant host. In this review, 11 patents were chronologically and unbiasedly selected from 454 that fit the criteria out of a 4,716,037 patents search. These patents highlight the novel approaches that have been used to tackle difficult fungi. The strategies include targeting key fungal structures and metabolic pathways, developing manufacturing processes of anti-fungal reagents, unique membrane interfering fungicides, and plant and insect defensins.

Keywords: Anti-infective agent; anti-fungal; sterol biosynthesis pathway; minimum inhibition concentration; cell cycle; pyrroline-5-carboxylate reductase (P5CR; glucan synthase pathway; defensin; ATP (CTP):tRNA nucleotidyltransferase; posttranslational modification

Document Type: Research article

DOI: 10.2174/157489106777452584

Affiliations: 1: Department of Biochemistry, Redox Biology Center, University of Nebraska, Lincoln, Nebraska 68588, USA.

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$105.07 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A